Results 91 to 100 of about 4,817 (129)

Epidemiology of Epileptic Spasm and Affecting Factors on One-Year Prognosis: A Study in Tabriz Children's Hospital. [PDF]

Iran J Child Neurol
Sadeghvand S, Kamali A, Mousavi M, Mahallei M, Shiva S, Magsudy A, Ahmadi Hajkolaie F, Erabi G, Dadashzadeh Asl A.   +8 more
europepmc   +1 more source

Subacute sclerosing panencephalitis in a child six years after measles infection. [PDF]

IDCases
Le Feur L, Henry S, Jeziorski E, Dina J, Piarroux J, Meyer P, Foulongne V.   +6 more
europepmc   +1 more source

Real-world disproportionality analysis of sleep disturbances associated with antiseizure medications in epilepsy: a pharmacovigilance study. [PDF]

Front Pharmacol
Gou C, Yang M, Zhao Q, Han Y.
europepmc   +1 more source

Pharmacovigilance study of drug-induced eye movement disorder based on FDA adverse event reports from 2004 to 2024. [PDF]

Sci Rep
Hong SY, Zhou CB, Chen XD, Zhu GP, Gao CH, Wang PH.   +5 more
europepmc   +1 more source

Cytotoxic Lesions of the Corpus Callosum Patterns and Etiologies: Insights from an Indian Cohort. [PDF]

Ann Indian Acad Neurol
Badachi S, Shivde S, Deepalam S, Nadig R, Kashif MS, Sarma G, Sharma VC, Bhardwaj S, Kumar GS, Mathew T.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vigabatrin

Clinical Pharmacokinetics, 2012
Elisabeth Rey, Gérard Pons, G Olive
exaly   +5 more sources

Vigabatrin

Seminars in Pediatric Neurology, 1997
Vigabatrin is a structural analogue of gamma amino butyric acid (GABA), which binds irreversibly to GABA-transaminase causing increased brain levels of GABA. It is an important advance in the medical management of children with epilepsy. It appears to be particularly effective in the treatment of infantile spasms, especially when caused by tuberous ...
W D, Shields, R, Sankar
  +5 more sources

Vigabatrin

Epilepsia, 1994
Summary: The discovery of γ‐aminobutyric acid (GABA) as the first major inhibitory neurotransmitter and a program exploring the use of enzyme inhibition as a therapeutic tool provided the basis for the conception of vigabatrin (VGB, Sabril). This molecule, an analogue of GABA, has a highly specific activity as an enzyme‐activated irreversible ...
J P, Mumford, D J, Cannon
  +5 more sources